Top compounds associated with response to MTCH2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA serdemetan FIMM pan-cancer AAC -0.18 0.3
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.042 0.3
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.032 0.3
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC 0.06 0.3
mRNA pluripotin CTRPv2 pan-cancer AAC -0.037 0.3
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.031 0.3
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.039 0.3
Download CSV